← Leaderboards
Sun Ha Choo
University Of California, San Diego
$982,214
Attributed
$2,946,641
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $624.3K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,946,641 · 1
By mechanism
R01$2,946,641 · 1
Top collaborators
- Richard D Kolodner5 shared
- Jean Y.J. Wang5 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Jason X.-J. Yuan$26,627,598
- Christopher David Putnam$993,339
- Omar Sultan Akbari$9,379,133
- Olivier Harismendy$2,501,824
Others in their field
Other Emerging Leaders on “Collection”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,108,663
- Leonard Freedman · Leidos Biomedical Research, Inc.$112,090,885
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Research focus
CollectionClinicAffectClustered Regularly Interspaced Short Palindromic RepeatsAdvanced DiseaseBar CodesBiological AvailabilityBiopsyAblationAdolescentAnimalsBrca GeneCancer CellCell DeathCell LineCellsCell TransformationCessation Of LifeAggressive TherapyChemotherapyChildChromosome BreakageBrca1 GeneCoupled
Grant awards (5)
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma$624,288
R01 · FY2025 · CA
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma$593,075
R01 · FY2024 · CA
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma$591,603
R01 · FY2023 · CA
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma$563,315
R01 · FY2022 · CA
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma$574,360
R01 · FY2021 · CA